Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B.

Rubio MF, Werbajh S, Cafferata EG, Quaglino A, Coló GP, Nojek IM, Kordon EC, Nahmod VE, Costas MA.

Oncogene. 2006 Mar 2;25(9):1367-77.

PMID:
16331275
[PubMed - indexed for MEDLINE]
2.

[The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells].

Wang HJ, Wu ZY, Fan P, Bian JM.

Zhonghua Wai Ke Za Zhi. 2005 Aug 1;43(15):1014-6. Chinese.

PMID:
16194364
[PubMed - indexed for MEDLINE]
3.

TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.

Rivas MA, Carnevale RP, Proietti CJ, Rosemblit C, Beguelin W, Salatino M, Charreau EH, Frahm I, Sapia S, Brouckaert P, Elizalde PV, Schillaci R.

Exp Cell Res. 2008 Feb 1;314(3):509-29. Epub 2007 Oct 13.

PMID:
18061162
[PubMed - indexed for MEDLINE]
4.

Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells.

Shah N, Thomas TJ, Lewis JS, Klinge CM, Shirahata A, Gelinas C, Thomas T.

Oncogene. 2001 Mar 29;20(14):1715-29.

PMID:
11313919
[PubMed - indexed for MEDLINE]
Free Article
5.

Crossroads of estrogen receptor and NF-kappaB signaling.

Biswas DK, Singh S, Shi Q, Pardee AB, Iglehart JD.

Sci STKE. 2005 Jun 14;2005(288):pe27. Review.

PMID:
15956359
[PubMed - indexed for MEDLINE]
6.

Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.

Jiang J, Slivova V, Sliva D.

Int J Oncol. 2006 Sep;29(3):695-703.

PMID:
16865287
[PubMed - indexed for MEDLINE]
7.

Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.

Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.

Oncogene. 2007 Feb 22;26(8):1201-12. Epub 2006 Aug 21.

PMID:
16924232
[PubMed - indexed for MEDLINE]
8.

AIB1 enhances estrogen-dependent induction of cyclin D1 expression.

Planas-Silva MD, Shang Y, Donaher JL, Brown M, Weinberg RA.

Cancer Res. 2001 May 15;61(10):3858-62.

PMID:
11358796
[PubMed - indexed for MEDLINE]
Free Article
9.

Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.

Singh S, Shi Q, Bailey ST, Palczewski MJ, Pardee AB, Iglehart JD, Biswas DK.

Mol Cancer Ther. 2007 Jul;6(7):1973-82.

PMID:
17620428
[PubMed - indexed for MEDLINE]
Free Article
10.

Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway.

Sethi G, Ahn KS, Sandur SK, Lin X, Chaturvedi MM, Aggarwal BB.

J Biol Chem. 2006 Aug 18;281(33):23425-35. Epub 2006 Jun 19.

PMID:
16785236
[PubMed - indexed for MEDLINE]
Free Article
11.
12.
13.

Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.

Qiu J, Wang X, Guo X, Zhao C, Wu X, Zhang Y.

Oncol Rep. 2009 Oct;22(4):935-41.

PMID:
19724876
[PubMed - indexed for MEDLINE]
14.

NF-kappa B activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-gamma and tumor necrosis factor-alpha.

Robinson CM, Hale PT, Carlin JM.

Cytokine. 2006 Jul;35(1-2):53-61. Epub 2006 Aug 22.

PMID:
16931033
[PubMed - indexed for MEDLINE]
15.

Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.

Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K.

Clin Cancer Res. 2007 Apr 1;13(7):2236-45.

PMID:
17404108
[PubMed - indexed for MEDLINE]
Free Article
16.

Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-kappaB/cyclin D1 pathway and facilitates tumor growth.

Liu S, Tan WY, Chen QR, Chen XP, Fu K, Zhao YY, Chen ZW.

Cancer Sci. 2008 May;99(5):952-7. doi: 10.1111/j.1349-7006.2008.00787.x. Epub 2007 Mar 12.

PMID:
18341653
[PubMed - indexed for MEDLINE]
17.

Mechanism of estrogen-induced apoptosis in breast cancer cells: role of the NF-kappaB signaling pathway.

Lobanova YS, Scherbakov AM, Shatskaya VA, Krasil'nikov MA.

Biochemistry (Mosc). 2007 Mar;72(3):320-7.

PMID:
17447886
[PubMed - indexed for MEDLINE]
18.

Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.

Ma G, Tabanca N, Husnu Can Baser K, Kirimer N, Pasco DS, Khan IA, Khan SI.

Cancer Chemother Pharmacol. 2009 Mar;63(4):673-80. doi: 10.1007/s00280-008-0784-9. Epub 2008 Jul 3.

PMID:
18597088
[PubMed - indexed for MEDLINE]
19.

[Activation and prognostic significance of AKT, NF-kappaB and STAT3 in breast cancer with lymph node metastasis and estrogen receptor expression].

Liu C, Zhou S, Ke CS, Li NP, Wu RL.

Ai Zheng. 2007 Sep;26(9):929-36. Chinese.

PMID:
17927847
[PubMed - indexed for MEDLINE]
20.

Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.

Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE.

Cancer Res. 2005 Dec 15;65(24):11375-83.

PMID:
16357145
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk